Actually, we mainly used AR-negative PC-3 and DU-145 for in vitro experiments, so it is indeed unclear whether ARPC1A plays a similar role in AR-positive prostate cancer cells, which is one of the main limitations of this study. This evidence concerns the gene AR and prostate carcinoma.